U.S. market Closed. Opens in 1 day 3 hours 49 minutes

OTLK | Outlook Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-30
RevenueN/AN/AN/AN/A8.15M3.09M3.81M2.98M5.22M9.05M
Cost of Revenue44.19K204.69K262.14K554.07K23.80K18.50K23.81K32.76K38.88K14.12K
Gross Profit-44.19K-204.69K-262.14K-554.07K8.12M3.07M3.79M2.95M5.18M9.04M
Operating Expenses53.13M63.07M51.73M36.31M29.33M25.48M39.69M51.93M51.78M21.44M
Selling, General & Admin26.67M20.74M13.05M8.08M5.52M6.97M13.19M19.17M12.91M7.32M
Research & Development26.45M42.33M38.96M26.34M23.81M18.50M23.81M32.76M38.88M14.12M
Other Operating ExpensesN/A-882.90KN/AN/AN/AN/AN/A0N/AN/A
Operating Income-53.13M-63.07M-51.73M-36.84M-36.30M-25.44M-35.88M-51.76M-46.56M-12.39M
Other Expenses / Income-5.85M-2.98M-1.43M-1.67M-1.64M-4.10M-2.47M-1.85M-2.30M-901.05K
Before Tax Income-58.98M-66.05M-53.16M-38.51M-37.93M-33.74M-38.35M-53.23M-48.86M-13.29M
Income Tax Expenses2.80K2.80K2.00K-3.27M-3.41M-3.65M501.50K103.00K-190.11K439.02K
Net Income-58.98M-66.05M-53.16M-35.24M-34.52M-46.11M-38.85M-53.33M-47.39M-13.73M
Interest Expenses1.56M1.49M936.00K1.76M3.47M3.89M5.63M1.47M2.30M901.05K
Basic Shares Outstanding12.51M10.60M7.63M3.63M909.59K909.59K150.14K107.58K93.95K88.40K
Diluted Shares Outstanding12.51M10.60M7.63M3.63M909.59K909.59K150.26K107.58K93.95K88.40K
EBITDA-57.38M-62.87M-51.46M-35.76M-31.11M-26.79M-30.03M-48.95M-44.74M-11.51M
EBITDA Margin0.00%0.00%0.00%0.00%-381.85%-867.82%-787.87%-1,642.95%-857.18%-127.22%
EBIT-57.42M-64.56M-52.23M-36.76M-34.47M-45.87M-32.72M-51.76M-45.29M-12.39M
EBIT Margin0.00%0.00%0.00%0.00%-423.12%-1,485.70%-858.50%-1,737.10%-867.68%-136.92%
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙